225 related articles for article (PubMed ID: 16448320)
21. Management of chronic stable angina pectoris.
Rodríguez-Ospina L; Montano-Soto L
Bol Asoc Med P R; 2008; 100(4):39-47. PubMed ID: 19400528
[TBL] [Abstract][Full Text] [Related]
22. Ranolazine: a review of its use in chronic stable angina pectoris.
Siddiqui MA; Keam SJ
Drugs; 2006; 66(5):693-710. PubMed ID: 16620147
[TBL] [Abstract][Full Text] [Related]
23. Ranolazine as add-on therapy for patients with severe chronic angina.
Pechlaner C; Wiedermann C
JAMA; 2004 Apr; 291(16):1959; author reply 1959-60. PubMed ID: 15113811
[No Abstract] [Full Text] [Related]
24. Does ranolazine have a place in the treatment of acute coronary syndromes?
Newby LK; Peterson ED
JAMA; 2007 Apr; 297(16):1823-5. PubMed ID: 17456825
[No Abstract] [Full Text] [Related]
25. Treatment of inoperable coronary disease and refractory angina: spinal stimulators, epidurals, gene therapy, transmyocardial laser, and counterpulsation.
Svorkdal N
Semin Cardiothorac Vasc Anesth; 2004 Mar; 8(1):43-58. PubMed ID: 15372127
[TBL] [Abstract][Full Text] [Related]
26. Ranolazine: a review of its use in chronic stable angina pectoris.
Keating GM
Drugs; 2008; 68(17):2483-503. PubMed ID: 19016575
[TBL] [Abstract][Full Text] [Related]
27. Ranolazine as add-on therapy for patients with severe chronic angina.
Hooper JS; Busti AJ
JAMA; 2004 Apr; 291(16):1959; author reply 1959-60. PubMed ID: 15113810
[No Abstract] [Full Text] [Related]
28. [Non-pharmacological, non-conventional therapy of chronic refractory angina pectoris].
Romanò M
Ital Heart J Suppl; 2001 Apr; 2(4):344-55. PubMed ID: 19397005
[TBL] [Abstract][Full Text] [Related]
29. Novel drugs for treating angina.
Jones DA; Timmis A; Wragg A
BMJ; 2013 Sep; 347():f4726. PubMed ID: 24018101
[No Abstract] [Full Text] [Related]
30. Ranolazine (Ranexa) in the treatment of chronic stable angina.
Aslam S; Gray D
Adv Ther; 2010 Apr; 27(4):193-201. PubMed ID: 20449698
[TBL] [Abstract][Full Text] [Related]
31. Impact of ranolazine on clinical outcomes and healthcare resource utilization in patients with refractory angina pectoris.
Ling H; Packard KA; Burns TL; Hilleman DE
Am J Cardiovasc Drugs; 2013 Dec; 13(6):407-12. PubMed ID: 23873327
[TBL] [Abstract][Full Text] [Related]
32. Expanding the understanding of the treatment of chronic angina: a 21st century approach-part II.
Conti CR
Clin Cardiol; 2008 Jul; 31(7):295-6. PubMed ID: 18636470
[TBL] [Abstract][Full Text] [Related]
33. Stable angina pectoris: current medical treatment.
Siama K; Tousoulis D; Papageorgiou N; Siasos G; Tsiamis E; Bakogiannis C; Briasoulis A; Androulakis E; Tentolouris K; Stefanadis C
Curr Pharm Des; 2013; 19(9):1569-80. PubMed ID: 23016717
[TBL] [Abstract][Full Text] [Related]
34. Treatment of Angina: Where Are We?
Balla C; Pavasini R; Ferrari R
Cardiology; 2018; 140(1):52-67. PubMed ID: 29874661
[TBL] [Abstract][Full Text] [Related]
35. Treatment of intractable angina pectoris utilizing spinal cord stimulation.
Mesa JE; Yakovlev AE
Rev Cardiovasc Med; 2008; 9(1):70-4. PubMed ID: 18418311
[TBL] [Abstract][Full Text] [Related]
36. The usefulness of ranolazine for the treatment of refractory chronic stable angina pectoris as determined from a systematic review of randomized controlled trials.
Banon D; Filion KB; Budlovsky T; Franck C; Eisenberg MJ
Am J Cardiol; 2014 Mar; 113(6):1075-82. PubMed ID: 24462341
[TBL] [Abstract][Full Text] [Related]
37. Ranolazine: focusing on angina pectoris.
McCullough PA
Drugs Today (Barc); 2006 Mar; 42(3):177-83. PubMed ID: 16628259
[TBL] [Abstract][Full Text] [Related]
38. Long-Term Preservation of Left Ventricular Systolic Function in Patients With Refractory Angina Pectoris and Inducible Myocardial Ischemia on Optimal Medical Therapy.
Slavich M; Maranta F; Fumero A; Godino C; Giannini F; Oppizzi M; Colombo A; Fragasso G; Margonato A
Am J Cardiol; 2016 May; 117(10):1558-1561. PubMed ID: 27055755
[TBL] [Abstract][Full Text] [Related]
39. Cost-utility of ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Spain.
Hidalgo-Vega A; Ramos-Goñi JM; Villoro R
Eur J Health Econ; 2014 Dec; 15(9):917-25. PubMed ID: 24122303
[TBL] [Abstract][Full Text] [Related]
40. Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study.
Melloni C; Newby LK
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):9-16. PubMed ID: 18095903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
